Sabzevari Helen

CIK 00017241952 companiesGERMANTOWN, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001724195

Recent Transactions

50 trades

Award
PRECIGEN, INC.$PGEN
Performance Stock Units
2025-09-12+825,000→ 825,000 total
Award
PRECIGEN, INC.$PGEN
Restricted Stock Units
2025-06-26+500,000→ 500,000 total
Award
PRECIGEN, INC.$PGEN
Option to Purchase Common Stock (Right to Buy)
2025-05-23+1,000,000→ 1,000,000 total
Tax Payment
PRECIGEN, INC.$PGEN
Common Stock
2025-05-16$1.45/sh−521,224→ 3,317,022 total
Exercise/Conversion
PRECIGEN, INC.$PGEN
Common Stock
2025-05-16+1,079,137→ 3,838,246 total
Exercise/Conversion
PRECIGEN, INC.$PGEN
Restricted Stock Units
2025-05-16−1,079,137→ 0 total
Award
PRECIGEN, INC.$PGEN
Restricted Stock Units
2025-04-17+1,079,137→ 1,079,137 total
Tax Payment
PRECIGEN, INC.$PGEN
Common Stock
2025-01-29$1.30/sh−286,967→ 2,759,109 total
Award
PRECIGEN, INC.$PGEN
Common Stock
2025-01-29+825,000→ 3,046,076 total
Award
PRECIGEN, INC.$PGEN
Option to Purchase Common Stock (Right to Buy)
2024-05-31+1,803,000→ 1,803,000 total
Exercise/Conversion
PRECIGEN, INC.$PGEN
Restricted Stock Units
2024-04-05−1,071,429→ 0 total
Exercise/Conversion
PRECIGEN, INC.$PGEN
Common Stock
2024-04-05+1,071,429→ 2,631,433 total
Award
PRECIGEN, INC.$PGEN
Restricted Stock Units
2024-04-05+1,071,429→ 1,071,429 total
Tax Payment
PRECIGEN, INC.$PGEN
Common Stock
2024-04-05$1.40/sh−410,357→ 2,221,076 total
Disposition to Issuer
Kinnate Biopharma Inc.
Stock Option (right to buy)
2024-04-03−40,501→ 0 total
Disposition to Issuer
Kinnate Biopharma Inc.
Stock Option (right to buy)
2024-04-03−20,250→ 0 total
Disposition to Issuer
Kinnate Biopharma Inc.
Stock Option (right to buy)
2024-04-03−25,000→ 0 total
Sale
PRECIGEN, INC.$PGEN
Common Stock
2023-08-25$1.53/sh−76,969→ 1,560,004 total
Exercise/Conversion
PRECIGEN, INC.$PGEN
Common Stock
2023-08-23+141,587→ 1,636,973 total
Exercise/Conversion
PRECIGEN, INC.$PGEN
Restricted Stock Units
2023-08-23−141,587→ 0 total
Sale
PRECIGEN, INC.$PGEN
Common Stock
2023-08-18$1.66/sh−55,855→ 1,495,386 total
Exercise/Conversion
PRECIGEN, INC.$PGEN
Restricted Stock Units
2023-08-16−141,587→ 141,587 total
Exercise/Conversion
PRECIGEN, INC.$PGEN
Common Stock
2023-08-16+141,587→ 1,551,241 total
Sale
PRECIGEN, INC.$PGEN
Common Stock
2023-08-11$1.44/sh−41,436→ 1,409,654 total
Exercise/Conversion
PRECIGEN, INC.$PGEN
Restricted Stock Units
2023-08-09−141,587→ 283,173 total
Exercise/Conversion
PRECIGEN, INC.$PGEN
Common Stock
2023-08-09+141,587→ 1,451,090 total
Sale
PRECIGEN, INC.$PGEN
Common Stock
2023-08-04$1.10/sh−52,870→ 1,309,503 total
Exercise/Conversion
PRECIGEN, INC.$PGEN
Restricted Stock Units
2023-08-02−141,587→ 424,760 total
Exercise/Conversion
PRECIGEN, INC.$PGEN
Common Stock
2023-08-02+141,587→ 1,362,373 total
Award
Kinnate Biopharma Inc.
Stock Option (right to buy)
2023-06-12+25,000→ 25,000 total
Award
PRECIGEN, INC.$PGEN
Option to Purchase Common Stock (Right to Buy)
2023-04-28+1,732,300→ 1,732,300 total
Exercise/Conversion
PRECIGEN, INC.$PGEN
Restricted Stock Units
2023-03-24−283,173→ 566,347 total
Award
PRECIGEN, INC.$PGEN
Restricted Stock Units
2023-03-24+849,520→ 849,520 total
Exercise/Conversion
PRECIGEN, INC.$PGEN
Common Stock
2023-03-24+283,173→ 1,220,786 total
Award
PRECIGEN, INC.$PGEN
Option to Purchase Common Stock (Right to Buy)
2023-03-24+369,596→ 369,596 total
Purchase
PRECIGEN, INC.$PGEN
Common Stock
2023-01-27$1.75/sh+22,857→ 937,613 total
Exercise/Conversion
PRECIGEN, INC.$PGEN
Common Stock
2023-01-04+17,665→ 914,756 total
Exercise/Conversion
PRECIGEN, INC.$PGEN
Restricted Stock Units
2023-01-04−17,665→ 0 total
Award
Kinnate Biopharma Inc.
Stock Option (right to buy)
2022-06-13+20,250→ 20,250 total
Sale
PRECIGEN, INC.$PGEN
Common Stock
2022-05-13$1.19/sh−177,968→ 897,091 total
Exercise/Conversion
PRECIGEN, INC.$PGEN
Restricted Stock Units
2022-05-12−340,909→ 0 total
Exercise/Conversion
PRECIGEN, INC.$PGEN
Common Stock
2022-05-12+340,909→ 1,075,059 total
Award
PRECIGEN, INC.$PGEN
Restricted Stock Units
2022-03-18+340,909→ 340,909 total
Award
PRECIGEN, INC.$PGEN
Option to Purchase Common Stock (Right to Buy)
2022-02-02+847,000→ 847,000 total
Sale
PRECIGEN, INC.$PGEN
Common Stock
2022-01-05$3.59/sh−1,357→ 739,753 total
Sale
PRECIGEN, INC.$PGEN
Common Stock
2022-01-05$3.59/sh−5,603→ 734,150 total
Exercise/Conversion
PRECIGEN, INC.$PGEN
Restricted Stock Units
2022-01-04−17,667→ 17,665 total
Exercise/Conversion
PRECIGEN, INC.$PGEN
Common Stock
2022-01-04+17,667→ 741,110 total
Sale
PRECIGEN, INC.$PGEN
Common Stock
2022-01-03$3.67/sh−3,848→ 723,443 total
Exercise/Conversion
PRECIGEN, INC.$PGEN
Restricted Stock Units
2022-01-02−9,765→ 0 total

Companies

Recent Filings

Address

20374 SENECA MEADOWS PARKWAY

GERMANTOWN, MD, 20876

View on SEC.gov